Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy

SIMPLE SUMMARY: Pancreas cancer will become the second deadliest cancer in 2030. One-third of patients with pancreatic cancer are treated with surgery followed by intravenous chemotherapy. This aggressive treatment has to be delivered to people fit enough to receive it. Many variables are used to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortier, Victor, Wei, Felix, Pellat, Anna, Marchese, Ugo, Dohan, Anthony, Brezault, Catherine, Barat, Maxime, Fuks, David, Soyer, Philippe, Coriat, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777189/
https://www.ncbi.nlm.nih.gov/pubmed/36551662
http://dx.doi.org/10.3390/cancers14246179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777189/
https://www.ncbi.nlm.nih.gov/pubmed/36551662
http://dx.doi.org/10.3390/cancers14246179

Ejemplares similares